Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2621 of 5804
-
Nighttime drug may boost recovery after surgery in seniors
Symptom relief Recruiting nowIn the aftermath of major surgery, many patients suffer from pain, fatigue, reduced general well-being, and cognitive dysfunction. Another common concern after major surgery is sleep impairment and there is little known about its effect on postoperative morbidity, especially post…
Phase: PHASE4 • Sponsor: Ziekenhuis Oost-Limburg • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
A new lens design aims to improve vision after cataract surgery
Disease control CompletedThe aim of this study is to investigate the 3-month visual performance of the CT LUCIA 621P IOL, a hydrophobic aspheric monofocal IOL with a non-constant aspheric optic profile in adult patients 50 years of age or older who are undergoing cataract surgery.
Phase: PHASE4 • Sponsor: Carl Zeiss Meditec AG • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
New MRI method could spare diabetics from painful kidney biopsies
Knowledge-focused Recruiting nowThe goal of this study is to investigate the value of noninvasive evaluation of multimodal magnetic resonance imaging in diagnosis and treatment of diabetic kidney disease (DKD). We aim to explore the feasibility of multimodal magnetic resonance imaging in the staging diagnosis o…
Sponsor: Shengjing Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Could a probiotic help pregnant women and their babies grow stronger?
Disease control CompletedStunting in young children refers to attenuated linear growth. In the year 2020, 149.2 million children under the age of 5 were stunted, accounting for 22% of stunting globally. Stunting has short- and long-term consequences of increased morbidity and mortality, impairment of neu…
Phase: PHASE2 • Sponsor: Institut Pasteur de Dakar • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Migraine drug shows promise for IBS belly pain in small study
Symptom relief CompletedThe primary aim of this study is to evaluate the efficacy of rimegepant on abdominal pain scores in participants with non-constipation IBS.
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Second radiation blast for belly tumors: safe or too risky?
Disease control OngoingThis research study will enroll people who have cancer in their abdomen or pelvis that was treated previously with radiation therapy. The purpose of this research study is to test the safety and possible harms of treating tumors in these regions with another round of radiation th…
Phase: NA • Sponsor: Baptist Health South Florida • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New hope for tough colorectal cancer: experimental drug combo enters human testing
Disease control TerminatedThis phase I trial tests the safety, best dose, and effectiveness of ZEN003694 in combination with cetuximab and encorafenib in treating patients with colorectal cancer that has not responded to previous treatment (refractory), that has come back after a period of improvement (re…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
New drug combo aims to control advanced cancers
Disease control Recruiting nowThis is a Phase 1a/1b, first-in-human (FIH), multi-center, open-label, non-randomized, dose escalation study, designed to determine the Maximum tolerated dose(MTD)/Recommended Phase 2 dose (RP2D) and to evaluate safety, tolerability, preliminary efficacy, pharmacokinetics, immuno…
Phase: PHASE1 • Sponsor: LG Chem • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New gel shows promise for thinning hair in early trial
Disease control CompletedThe study is a two part study, designed to validate safety results from the Phase 1 PP405-001 trial while also characterizing longer term safety and PK. Part 1 of the trial is the randomized controlled portion that will focus on safety and PK following 28 days of blinded treatmen…
Phase: PHASE2 • Sponsor: Pelage Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New combo drug doses aim to wipe out whipworm in toddlers
Disease control CompletedThis study is a single-blind randomized controlled dose-ranging trial aiming at providing evidence on the on the optimal dose of co-administered ivermectin and albendazole in terms of efficacy, safety and acceptability in preschool-aged children (PSAC; aged 2-5 years) infected wi…
Phase: PHASE2 • Sponsor: Jennifer Keiser • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Could a simple wash cut C-Section infections?
Disease control Recruiting nowThis investigator-initiated, open-label, randomized controlled trial will explore the effects of two treatment arms, comparing standard treatment with normal saline against Irrisept, a jet lavage solution containing a low concentration of Chlorhexidine Gluconate (CHG) at 0.05% in…
Phase: NA • Sponsor: Loma Linda University • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Could a simple supplement shield kidneys from disease?
Disease control CompletedThe objective is to explore the effects of adding AC-134 on renal function, proteinuria, uremic toxins, and metabolism-related markers in chronic kidney disease.
Phase: NA • Sponsor: Taichung Veterans General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Balloon in the aorta: a new hope for cardiac arrest?
Knowledge-focused Recruiting nowThis study will assess the feasibility of performing pre-hospital resuscitative endovascular balloon occlusion of the aorta (REBOA) as an adjunct to conventional Advanced Life Support (ALS) in patients suffering from non-traumatic out of hospital cardiac arrest (OHCA). As well as…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Childhood trauma survivors: new study probes hidden dissociative disorder rates
Knowledge-focused Recruiting nowThe investigators will study the prevalence of dissociative identity disorder (DID) in three populations at risk in cases of childhood psychotrauma : patients with a diagnosis of borderline personality, patients with a diagnosis of functional dissociative crises (FDC) and patient…
Phase: NA • Sponsor: Centre Psychothérapique de Nancy • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can money skills and mentors shield AIDS orphans from HIV?
Disease control OngoingThe goal of this clinical trial is to compare two multifaceted strategies (standard vs enhanced) for scaling Bridges in a two-arm Hybrid III effectiveness-implementation cluster randomized controlled trial (RCT) in adolescent and youths affected by AIDS \[AYaAIDS\] (ages 11-17 ye…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a common diabetes drug shrink prostate tumors?
Disease control TerminatedThis is a pilot study of the tolerability and safety of neoadjuvant dapagliflozin for patients with unfavorable intermediate, high-risk, or very high-risk prostatic adenocarcinoma prior to radical prostatectomy. The primary hypothesis is that four weeks of daily dapagliflozin pri…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New hope for tough blood cancers? early trial launches
Disease control Recruiting nowThis is an open-label, Phase 1 study to determine the safety, tolerability, and efficacy of APL-4098 alone, and in combination with azacitidine, and in combination with azacitidine plus venetoclax for the treatment of acute myeloid leukemia (AML), myelodysplastic syndrome (MDS)/A…
Phase: PHASE1 • Sponsor: Apollo Therapeutics Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Art as medicine: new study tests if painting eases cancer symptoms in kids
Symptom relief Recruiting nowThis clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos can affect symptoms and impact the quality of life in children with cancer. Creative arts mind-body interventions (CrA) ar…
Phase: NA • Sponsor: OHSU Knight Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
New gel shows promise for vitiligo, but study halted early
Disease control TerminatedThe purpose of this study is to evaluate the efficacy, safety, and pharmacokinetics of VYN201 Gel in subjects with non-segmental vitiligo.
Phase: PHASE2 • Sponsor: Vyne Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New active rehab program aims to get soldiers back on duty faster after concussion
Symptom relief Recruiting nowThe strategic objective of this research line is to examine improving short- and long-term outcomes for soldiers following mild traumatic brain injury (mTBI). The technical objectives are to: 1) conduct a Phase 1 quasi-experimental pragmatic trial testing the potential benefit of…
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC